Vincent J. Roth serves as Executive at CardioVascular BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Vincent J. Roth has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2016 involved receiving (via award) 15,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 31, 2016 | NONE | $0 | Award | 15,000 | $N/A | Discretionary |
| Dec 31, 2016 | NONE | $0 | Award | 15,000 |
Vincent J. Roth currently holds 265,000 shares of CardioVascular BioTherapeutics, Inc. (CVBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vincent J. Roth has been a net neutral trader of CVBT stock. They have purchased $0 and sold $0 worth of shares.
Vincent J. Roth's most recent insider trade was on Dec 31, 2016, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 22, 2006 | CVBT | $0 | Award | 1 | $N/A | Discretionary |